Motif Neurotech Raises $18.75M for Implantable Device for Treatment-Resistant Depression
HIT Consultant
JANUARY 26, 2024
What You Should Know: – Motif Neurotech , a pioneer in minimally-invasive bioelectronics for mental health, announced today an impressive $18.75 million Series A funding round. Led by Arboretum Ventures , the investment saw participation from prominent players like KdT Ventures, Satori Neuro , and Dolby Family Ventures, alongside existing supporters Divergent Capital and PsyMed Ventures. – Motif Neurotech’s innovative approach represents a potential paradigm shift in mental hea
94 94
Let's personalize your content